A Randomized, Double-blind, Dose-ranging, Placebo-controlled Study to Evaluate the Efficacy and Safety of Bexotegrast (PLN-74809) for the Treatment of Idiopathic Pulmonary Fibrosis (BEACON-IPF).

In: Clinical Trials Week, 2023-11-06, S. 95-95

serialPeriodical

Keywords: Cancer; Carcinomas; Clinical Research; Clinical Trials and Studies; Drugs and Therapies; Health and Medicine; Idiopathic Interstitial Pneumonias; Idiopathic Pulmonary Fibrosis; Lung Diseases and Conditions; Lung Diseases and Conditions - Idiopathic Pulmonary Fibrosis; Oncology; Placebos; Respiratory Tract Diseases and Conditions; Respirology EN Cancer Carcinomas Clinical Research Clinical Trials and Studies Drugs and Therapies Health and Medicine Idiopathic Interstitial Pneumonias Idiopathic Pulmonary Fibrosis Lung Diseases and Conditions Lung Diseases and Conditions - Idiopathic Pulmonary Fibrosis Oncology Placebos Respiratory Tract Diseases and Conditions Respirology 95 95 1 11/06/23 20231106 NES 231106 2023 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Staff editors report on the newly launched clinical trial, NCT06097260, which has the following summary description: "A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of bexotegrast (PLN-74809) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)." Cancer, Carcinomas, Clinical Research, Clinical Trials and Studies, Drugs and Therapies, Health and Medicine, Idiopathic Pulmonary Fibrosis, Lung Diseases and Conditions, Lung Diseases and Conditions - Idiopathic Pulmonary Fibrosis, Oncology, Placebos, Respiratory Tract Diseases and Conditions, Respirology, Idiopathic Interstitial Pneumonias. [Extracted from the article]

Copyright of Clinical Trials Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Titel:	A Randomized, Double-blind, Dose-ranging, Placebo-controlled Study to Evaluate the Efficacy and Safety of Bexotegrast (PLN-74809) for the Treatment of Idiopathic Pulmonary Fibrosis (BEACON-IPF).
Zeitschrift:	Clinical Trials Week, 2023-11-06, S. 95-95
Veröffentlichung:	2023
Medientyp:	serialPeriodical
ISSN:	1543-6772 (print)
Schlagwort:	IDIOPATHIC interstitial pneumonias RESPIRATORY diseases IDIOPATHIC pulmonary fibrosis PULMONARY fibrosis THERAPEUTICS MEDICAL research PULMONARY hypertension KIDNEY transplantation
Sonstiges:	Nachgewiesen in: Complementary Index Sprachen: English

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.